WFL

0.00%

0.3¢ wellfully limited

Ann: Presentation, page-148

First 148 Last

Share
Profile

Follow
gbr

675 Posts.

150

07/03/16

23:55

Post #: 17211946
Share

Originally posted by cmk1969 ↑

'What I like about this is that Nurofen and Voltaren are not owned by P&G. We are dealing with more of the largest FMCG's.'

We always have been dealing with more than just little ole P&G, via FMCG's, Pharmaceutical's & Beauty Companies. Here are a few logo's for you to ponder over Doss - compliments of Abdm and a couple extra Brands & Companies I have added at the bottom. These are only the ones that we currently know about :

View attachment 152649

View attachment 152652

View attachment 152655

View attachment 152656
View attachment 152657

View attachment 152658

Expand

Hi cmk1969,

A little gem that may have slipped past you [and others],

Dermatology company Galderma, founded in 1981 as a joint venture between Nestlé and L'Oréal.

February 11, 2014
Tuesday 11th February, 2014 - (Lausanne, Switzerland). Today, Nestlé S.A. (Nestlé) announced the creation of Nestlé Skin Health S.A., a global leader focused on meeting the world’s increasing skin health needs with a scientifically-proven broad range of innovative products. The company will be formed by the acquisition of 50% of Galderma Pharma S.A. (Galderma), subject to regulatory clearance. Galderma was established in 1981 as a dermatology-focused, Swiss-based joint-venture between Nestlé and L’Oréal S.A. (L’Oréal) and had sales of CHF 2.0 billion in calendar year 2013.

Nestlé chairman Peter Brabeck-Letmathe said “Building on Nestlé’s historic strengths as a science based Nutrition, Health & Wellness Company and through the recent creation of Nestlé Health Science S.A., the company has reinforced its strategic direction to offer nutritional solutions from food & beverage to scientific products for a healthier life. By creating Nestlé Skin Health S.A. and by leveraging Galderma’s current portfolio, formulations and innovative research, Nestlé will now be able to provide science-based solutions for skin conditions. We strive to have a portfolio of innovative products that meet the full spectrum of people’s skin health needs over the course of their lives and to provide a holistic approach to people’s health.”

The establishment of Nestlé Skin Health will allow the emergence of a global leader that will leverage Galderma’s and Nestlé’s commercial operations throughout the world. Galderma’s Scientific Division, with laboratories located in France, Sweden, United States, Japan and Switzerland, will become part of Nestlé Skin Health and will actively collaborate with Nestlé’s global R&D network. Galderma’s 33 commercial subsidiaries around the world will continue to deliver scientifically-defined and medically-proven products to patients and healthcare providers around the world under the Galderma brand and organization.

Responding to increasing consumer needs, Nestlé will extend its activities to include the field of specialized, medical skin treatments through the creation of Nestlé Skin Health S.A., a global leader focused on meeting the world’s increasing skin health needs with a scientifically-proven broad range of innovative products. Nestlé Skin Health S.A. will be managed as a wholly-owned subsidiary of Nestlé S.A., with its own Board of Directors, located in Lausanne, Switzerland. Upon the approval and completion of Nestlé’s acquisition of the 50% stake of Galderma from L’Oréal, Galderma will form the foundation of Nestlé Skin Health S.A.

http://www.galderma.com/News/articleType/ArticleView/articleId/56/Nestle-Skin-Health-Is-Created-Targeting-Global-Skin-Health-Needs

Expand

Although it appears that Nestle now owns 100% of Galderma it is rather intriguing that we are now dealing with both companies

OBJ Price at posting: 7.8¢ Sentiment: Buy Disclosure: Held
29 Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BUX

Buxton projects new graphite province discovery at WA Narryer play

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

There are more pages in this discussion • 42 more messages in this thread...

First 148 Last

Add WFL (ASX) to my watchlist

(20min delay)
Last 0.3¢		Change 0.000(0.00%)		Mkt cap ! $1.478M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Ann: Presentation, page-148

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI reaches close of funding facility for salt-first part of Mardie project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Buxton projects new graphite province discovery at WA Narryer play

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News

Featured News

Ann: Presentation, page-148

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI reaches close of funding facility for salt-first part of Mardie project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Buxton projects new graphite province discovery at WA Narryer play

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News

Featured News